P3 Health Partners Inc. current report, 14 October 2022

Abrir documento

P3 Health Partners Inc. — Form 8-K Summary

Business Context and Reporting Period

P3 Health Partners Inc. filed a Form 8-K relating to corporate leadership changes and the announcement of financial results for the three and six months ended June 30, 2022. The filing identifies October 14, 2022 as the report date, while stating that the results announcement and exhibit were dated October 20, 2022.

Key Financial Metrics

The filing references financial results for the three and six months ended June 30, 2022, but the supplied text does not include the related press release or clear values for revenue, profit or loss, cash flow, margins, debt, liquidity, or other financial metrics.

Material Changes Versus Prior Period

  • No quantitative year-over-year or sequential comparisons are provided in the supplied filing text.
  • Eric Atkins resigned as Chief Financial Officer effective November 1, 2022.
  • Erin Darakjian was appointed Interim Chief Financial Officer effective November 1, 2022, and succeeded Mr. Atkins as principal financial officer and principal accounting officer.

Guidance, Outlook, Risks, and Unusual Items

  • The company stated that Mr. Atkins’s resignation was not due to any disagreement with the company regarding its operations, policies, or practices.
  • Ms. Darakjian will serve on an interim basis while the company searches for a permanent CFO.
  • No guidance, forecast, material contingency, or risk commentary is included in the supplied text.
  • The filing incorporates a results press release as Exhibit 99.1, but that exhibit’s contents are not included in the source provided.

Investor Verification Items

  1. Obtain and review Exhibit 99.1 for the actual second-quarter 2022 financial results, comparative figures, non-GAAP measures, and management outlook.
  2. Verify the effective date and transition arrangements for the CFO change.
  3. Assess whether the interim CFO appointment affects financial reporting, internal controls, or the timing of future filings.
  4. Confirm the apparent date discrepancy between the stated Form 8-K report date of October 14, 2022 and the October 20, 2022 results announcement and filing date.